IBDEI1C5 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23949,0)
 ;;=20550^^142^1491^16^^^^1
 ;;^UTILITY(U,$J,358.3,23949,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23949,1,2,0)
 ;;=2^Injection; tendon sheath, ligament, ganglion cyst
 ;;^UTILITY(U,$J,358.3,23949,1,3,0)
 ;;=3^20550
 ;;^UTILITY(U,$J,358.3,23950,0)
 ;;=20500^^142^1491^10^^^^1
 ;;^UTILITY(U,$J,358.3,23950,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23950,1,2,0)
 ;;=2^Injection of sinus tract; therapeutic diagnostic
 ;;^UTILITY(U,$J,358.3,23950,1,3,0)
 ;;=3^20500
 ;;^UTILITY(U,$J,358.3,23951,0)
 ;;=96402^^142^1491^9^^^^1
 ;;^UTILITY(U,$J,358.3,23951,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23951,1,2,0)
 ;;=2^Injec,IM,anti-neplastic horm
 ;;^UTILITY(U,$J,358.3,23951,1,3,0)
 ;;=3^96402
 ;;^UTILITY(U,$J,358.3,23952,0)
 ;;=64450^^142^1491^12^^^^1
 ;;^UTILITY(U,$J,358.3,23952,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23952,1,2,0)
 ;;=2^Injection, Nerve Block
 ;;^UTILITY(U,$J,358.3,23952,1,3,0)
 ;;=3^64450
 ;;^UTILITY(U,$J,358.3,23953,0)
 ;;=96360^^142^1491^7^^^^1
 ;;^UTILITY(U,$J,358.3,23953,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23953,1,2,0)
 ;;=2^Hydration IV Inf,31-60 min
 ;;^UTILITY(U,$J,358.3,23953,1,3,0)
 ;;=3^96360
 ;;^UTILITY(U,$J,358.3,23954,0)
 ;;=96361^^142^1491^8^^^^1
 ;;^UTILITY(U,$J,358.3,23954,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23954,1,2,0)
 ;;=2^Hydration IV Infus,Ea Add Hr
 ;;^UTILITY(U,$J,358.3,23954,1,3,0)
 ;;=3^96361
 ;;^UTILITY(U,$J,358.3,23955,0)
 ;;=96365^^142^1491^18^^^^1
 ;;^UTILITY(U,$J,358.3,23955,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23955,1,2,0)
 ;;=2^Ther/Proph/Diag IV Inf,Init Hr
 ;;^UTILITY(U,$J,358.3,23955,1,3,0)
 ;;=3^96365
 ;;^UTILITY(U,$J,358.3,23956,0)
 ;;=96366^^142^1491^17^^^^1
 ;;^UTILITY(U,$J,358.3,23956,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23956,1,2,0)
 ;;=2^Ther/Proph/Diag IV Inf,Ea Add Hr
 ;;^UTILITY(U,$J,358.3,23956,1,3,0)
 ;;=3^96366
 ;;^UTILITY(U,$J,358.3,23957,0)
 ;;=96372^^142^1491^19^^^^1
 ;;^UTILITY(U,$J,358.3,23957,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23957,1,2,0)
 ;;=2^Ther/Proph/Diag Inj, SC/IM
 ;;^UTILITY(U,$J,358.3,23957,1,3,0)
 ;;=3^96372
 ;;^UTILITY(U,$J,358.3,23958,0)
 ;;=20501^^142^1491^11^^^^1
 ;;^UTILITY(U,$J,358.3,23958,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23958,1,2,0)
 ;;=2^Injection of sinus tract;diagnostic
 ;;^UTILITY(U,$J,358.3,23958,1,3,0)
 ;;=3^20501
 ;;^UTILITY(U,$J,358.3,23959,0)
 ;;=20604^^142^1491^4^^^^1
 ;;^UTILITY(U,$J,358.3,23959,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23959,1,2,0)
 ;;=2^Arthroc,Aspir/Inj Sm Joint/Bursa,US,Rec/Rpt
 ;;^UTILITY(U,$J,358.3,23959,1,3,0)
 ;;=3^20604
 ;;^UTILITY(U,$J,358.3,23960,0)
 ;;=20606^^142^1491^2^^^^1
 ;;^UTILITY(U,$J,358.3,23960,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23960,1,2,0)
 ;;=2^Arthroc,Aspir/Inj Joint/Bursa,US,Rec/Rpt
 ;;^UTILITY(U,$J,358.3,23960,1,3,0)
 ;;=3^20606
 ;;^UTILITY(U,$J,358.3,23961,0)
 ;;=20612^^142^1491^5^^^^1
 ;;^UTILITY(U,$J,358.3,23961,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23961,1,2,0)
 ;;=2^Aspirate/Inj Ganglion Cyst
 ;;^UTILITY(U,$J,358.3,23961,1,3,0)
 ;;=3^20612
 ;;^UTILITY(U,$J,358.3,23962,0)
 ;;=J0690^^142^1492^1^^^^1
 ;;^UTILITY(U,$J,358.3,23962,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23962,1,2,0)
 ;;=2^Cefazolin Sodium Inj 500mg
 ;;^UTILITY(U,$J,358.3,23962,1,3,0)
 ;;=3^J0690
 ;;^UTILITY(U,$J,358.3,23963,0)
 ;;=S0077^^142^1492^2^^^^1
 ;;^UTILITY(U,$J,358.3,23963,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23963,1,2,0)
 ;;=2^Clindamycin Phosphate Inj 300mg
 ;;^UTILITY(U,$J,358.3,23963,1,3,0)
 ;;=3^S0077
 ;;^UTILITY(U,$J,358.3,23964,0)
 ;;=J3360^^142^1492^4^^^^1
